N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)-3-(phenethoxy)propanamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy
申请人:AstraZeneca AB
公开号:US08017602B2
公开(公告)日:2011-09-13
The present invention provides a compound of formula (I)
wherein W, R1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
本发明提供了一种化合物(I)的公式,其中W、R1、R2和R3如规范所定义,以及它们的制备方法、含有它们的药物组合物和它们在治疗中的应用。